ResearcherLanzhou UniversityActive in the last 2 years

Jie Yang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-3177-3033; OpenAlex author ID A5101647979. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 3

Papers, trials and grants by year

2025: 2 papers

Papers 2

YTHDF1 promotes pancreatic cancer cell progression by enhancing SF3B2 translation though m6A modification. Co-author DOI 10.1093/jb/mvaf018 ↗
Targeting early diagnosis and treatment of pancreatic cancer among the diabetic population: a comprehensive review of biomarker screening strategies. Co-author DOI 10.1186/s13098-025-01750-4 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Huijuan Cheng · 1 shared paper, 2025 · strength 0.30
- Paper Targeting early diagnosis and treatment of pancreatic cancer among the diabetic population: a comprehensive review of b… DOI 10.1186/s13098-025-01750-4 ↗
Xiaoming Wang · 1 shared paper, 2025 · strength 0.28
- Paper YTHDF1 promotes pancreatic cancer cell progression by enhancing SF3B2 translation though m6A modification. DOI 10.1093/jb/mvaf018 ↗
Chunyang Wang · 1 shared paper, 2025 · strength 0.28
- Paper YTHDF1 promotes pancreatic cancer cell progression by enhancing SF3B2 translation though m6A modification. DOI 10.1093/jb/mvaf018 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.